Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...
Clinicians have traditionally been wary about prescribing multiple targeted therapies for rheumatologic conditions for fear of increasing risk of infection. This study examined a large insurance ...
Advancements in drug development, rising disease awareness, and enhanced diagnostics are driving the psoriatic arthritis treatment market. Key opportunities lie in biologic and targeted therapies, ...
The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.
People with psoriatic arthritis (PsA) often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body's immune system and help to ...
Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
If you have psoriatic arthritis, carrying around excess weight can stress your joints. Here's how to lose weight and improve joint health.
Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading ...
In the past, biosimilar makers have been able to invalidate some of those patents through a sped-up process called “inter ...
Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...